WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2015126737) PYRAZOLOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2015/126737    International Application No.:    PCT/US2015/015742
Publication Date: 27.08.2015 International Filing Date: 13.02.2015
IPC:
C07D 498/22 (2006.01), C07D 211/48 (2006.01), A61K 31/529 (2006.01), A61P 31/18 (2006.01)
Applicants: VIIV HEALTHCARE (NO.5) LIMITED [GB/GB]; 980 Great West Road Brentford, Middlesex TW89GS (GB)
Inventors: NAIDU, B. Narasimhulu; (US).
WALKER, Michael A.; (US).
SORENSON, Margaret E.; (US).
PATEL, Manoj; (US).
ZHENG, Zhizhen Barbara; (US).
KADOW, John F.; (US).
ZHENG, Bin; (US).
EASTGATE, Martin D.; (US).
CHEN, Ke; (US).
GONZALEZ-BOBES, Francisco; (US)
Agent: BRINK, Robert; (US)
Priority Data:
61/941,931 19.02.2014 US
14/619,728 11.02.2015 US
Title (EN) PYRAZOLOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
(FR) MACROCYCLES DE PYRAZOLOPYRIMIDINE EN TANT QU'INHIBITEURS DE LA RÉPLICATION DU VIRUS DE L'IMMUNODÉFICIENCE HUMAINE
Abstract: front page image
(EN)The disclosure generally relates to compounds of formula (I), including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for making and using these compounds in the treatment of HIV infection.
(FR)L'invention concerne, de manière générale, des composés de formule (I), y compris des compositions et des méthodes pour traiter l'infection par le virus de l'immunodéficience humaine (VIH). L'invention concerne de nouveaux inhibiteurs du VIH, des compositions pharmaceutiques les contenant, ainsi que des méthodes de préparation et d'utilisation de ces composés dans le traitement de l'infection par le VIH.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)